Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Yee Chung Cheng MD

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Member of the Cancer Center


Publications

  • Does Progesterone Receptor Matter in the Risk of Recurrence for Patients With Ductal Carcinoma in Situ? (Chaudhary LN, Jawa Z, Hanif A, Szabo A, Kamaraju S, Cheng YC, Chitambar CR) WMJ 2018 Jun;117(2):62-67 PMID: 30048574 07/27/2018    
  • Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation. (Cheng YC, Shi Y, Zhang MJ, Brazauskas R, Hemmer MT, Bishop MR, Nieto Y, Stadtmauer E, Ayash L, Gale RP, Lazarus H, Holmberg L, Lill M, Olsson RF, Wirk BM, Arora M, Hari P, Ueno N) J Cancer 2017;8(6):1009-1017 PMID: 28529613 PMCID: PMC5436253 05/23/2017    
  • Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling. (Dong L, Yuan Y, Opansky C, Chen Y, Aguilera-Barrantes I, Wu S, Yuan R, Cao Q, Cheng YC, Sahoo D, Silverstein RL, Ren B) Oncotarget 2017 Apr 04;8(14):22550-22562 PMID: 28186980 PMCID: PMC5410244 02/12/2017       6 Citations
  • A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer. (Yao X, Hosenpud J, Chitambar CR, Charlson J, Cheng YC) J Cancer 2012;3:145-51 PMID: 22481980 PMCID: PMC3319980 04/07/2012    
  • Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients. (Cheng YC, Takagi M, Milbourne A, Champlin RE, Ueno NT) Oncologist 2012;17(2):233-8 PMID: 22282904 PMCID: PMC3286172 01/28/2012       15 Citations
  • Improvement of survival and prospect of cure in patients with metastatic breast cancer. (Cheng YC, Ueno NT) Breast Cancer 2012 Jul;19(3):191-9 PMID: 21567170 PMCID: PMC3860359 05/14/2011       31 Citations
  • Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients. (Cheng YC, Valero V, Davis ML, Green MC, Gonzalez-Angulo AM, Theriault RL, Murray JL, Hortobagyi GN, Ueno NT) Br J Cancer 2010 Oct 26;103(9):1331-4 PMID: 20877352 PMCID: PMC2990606 09/30/2010       6 Citations
  • Carboplatin and docetaxel-induced acute pancreatitis: brief report. (Singh V, Devata S, Cheng YC) Int J Clin Oncol 2010 Dec;15(6):642-4 PMID: 20602134 07/06/2010       8 Citations
  • Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. (Cheng YC, Rondón G, Sanchez LF, McMannis JD, Couriel DR, de Lima MJ, Hosing C, Khouri IF, Giralt SA, Champlin RE, Ueno NT) Int J Hematol 2009 Dec;90(5):627-634 PMID: 19998065 12/10/2009       4 Citations
  • Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer. (de Souza JA, Davis ML, Rondon G, Cheng YC, Jones RB, Champlin RE, Ueno NT) Bone Marrow Transplant 2009 Jul;44(2):81-7 PMID: 19448681 05/19/2009       9 Citations
  • Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report. (Flejsierowicz M, Ahmed MS, Kotov P, Cheng YC) WMJ 2008 Jul;107(4):191-4 PMID: 18702436 08/16/2008       6 Citations
  • Long-term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma. (Ahmed MS, Kroft SH, Davis NB, King DM, Cheng YC) Leuk Res 2008 Sep;32(9):1476-9 PMID: 18308388 03/01/2008       3 Citations
  • Primary mediastinal embryonal carcinoma masquerading as chronic pancreatitis. (Kaikobad M, Cheng YC, Choi H, Teves D) WMJ 2007 Jul;106(4):225-8 PMID: 17844714 09/12/2007       1 Citations
  • jenkins-FCD Prod-310 bff9d975ec7f2d302586822146c2801dd4449aad